UAMS Receives $1M Grant for Two Clinical Trials on Opioid Withdrawal in Infants

The University of Arkansas for Medical Sciences (UAMS), in collaboration with the Duke Clinical Research Institute, has received a $1 million federal grant for two clinical trials involving infants with neonatal opioid withdrawal syndrome (NOWS).

The increase in maternal opioid use has resulted in a rise in the number of infants born with NOWS. The $1,066,433 in funding comes from the National Institutes of Health (NIH) Helping to End Addiction Long-term (HEAL) Initiative SM, an aggressive, trans-agency effort to speed scientific solutions to stem the national opioid public health crisis.

At UAMS, Jeannette Lee, Ph.D., professor of biostatistics, and Jessica Snowden, M.D., associate professor of pediatrics, are leaders of the Data Coordinating and Operations Center for the Environmental influences on Child Health Outcomes (ECHO) IDeA States Pediatric Clinical Trials Network, which will conduct the trials in conjunction with the Neonatal Research Network, which is funded by the Eunice Shriver Kennedy National Institute for Child Health and Human Development. Both trials aim to address management of infants exposed in utero to opioids.

Read the full story from UAMS here.